Ozempic’s New Pill Form Could Change Who Has Access
Novo Nordisk has begun selling an oral version of semaglutide in the United States under the Ozempic name, a move that extends one of the most recognized drug brands in recent memory into a format that does not require an injection. The pill became available on May 4, 2026, at more than 70,000 pharmacies nationwide, […]
The alarming truth about stopping GLP-1 drugs and heart health
For patients with type 2 diabetes who take GLP-1 medications, the cardiovascular benefits do not come quickly but they can disappear fast. That is the central and sobering finding of a newly published study in the British Medical Journal, which followed more than 333,000 adults with type 2 diabetes over three years to examine what […]
Revolutionary drug combination promises new hope for diabetes treatment
A groundbreaking study recently published in Science Translational Medicine reveals that a novel drug combination could significantly enhance the treatment of both type 1 and type 2 diabetes by regenerating insulin-producing cells in the pancreas. Understanding the breakthrough Researchers have discovered that combining exendin-4, a common diabetes medication, with harmine, a DYRK1A enzyme inhibitor, can […]